Rahul Sarugaser
Stock Analyst at Raymond James
(4.76)
# 132
Out of 4,413 analysts
15
Total ratings
41.67%
Success rate
87.07%
Average return
Main Sectors:
Top Industries:
6 Stocks
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ONCY Oncolytics Biotech | Initiates: Outperform | $3 | $1.11 | +170.27% | 1 | Apr 4, 2024 | |
| FUSN Fusion Pharmaceuticals | Downgrades: Market Perform | n/a | $21.43 | - | 6 | Mar 20, 2024 | |
| QIPT Quipt Home Medical | Downgrades: Market Perform | $10 | $3.60 | +177.78% | 1 | Feb 16, 2024 | |
| DNA Ginkgo Bioworks Holdings | Downgrades: Market Perform | $2.5 | $0.89 | +180.55% | 3 | Nov 15, 2023 | |
| PROF Profound Medical | Downgrades: Outperform | n/a | $7.44 | - | 2 | Aug 4, 2023 | |
| VFF Village Farms International | Downgrades: Market Perform | $11 → $2.5 | $1.53 | +63.40% | 2 | Feb 27, 2023 |
Oncolytics Biotech
Apr 4, 2024
Initiates: Outperform
Price Target: $3
Current: $1.11
Upside: +170.27%
Fusion Pharmaceuticals
Mar 20, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $21.43
Upside: -
Quipt Home Medical
Feb 16, 2024
Downgrades: Market Perform
Price Target: $10
Current: $3.60
Upside: +177.78%
Ginkgo Bioworks Holdings
Nov 15, 2023
Downgrades: Market Perform
Price Target: $2.5
Current: $0.89
Upside: +180.55%
Profound Medical
Aug 4, 2023
Downgrades: Outperform
Price Target: n/a
Current: $7.44
Upside: -
Village Farms International
Feb 27, 2023
Downgrades: Market Perform
Price Target: $11 → $2.5
Current: $1.53
Upside: +63.40%